posted on Oct, 16 2014 @ 08:43 AM
The vaccine trials referred to in the OP are going on now. Here is a link to a
from about a month ago.
Glaxo Smith-Kline is making 10,000-20,000 doses, to be ready for delivery if it passes this safety trial, but unfortunately, there is no way of
knowing the efficacy of the vaccine until it is in people on the ground in Africa.
This vaccine is made to combat the Zaire strain only.
The other problem, even if this vaccine is good at stopping infection of ebola, is that it must be kept below freezing until administered. So, they
will be able to give it to health care workers, which is great, but a version of the vaccine that is stable at room temperatures, is years away. Not
such good news for the general population in the ravaged countries.
Just a sobering update on the deaths associated with this outbreak, as of 15 October 2014, from the WHO. The figures in the OP are very outdated.
WHO sitrep 1.5mb .pdf
A total of 8997 confirmed, probable, and suspected cases of Ebola virus disease (EVD) have been
reported in seven affected countries (Guinea, Liberia, Nigeria, Senegal, Sierra Leone, Spain, and the
United States of America) up to the end of 12 October. There have been 4493 deaths.
Also keep in mind, that these official statistics are thought to under-report the true number of cases and deaths, because not everyone infected has
been accounted for.
edit on 10/16/2014 by Olivine because: add a thought
Another vaccine trial began 2 days ago, in Maryland.
The Russians and Chinese also have candidates.
edit on 10/16/2014 by Olivine because: forgot an article